Top Markets
Coin of the day
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Rank in Stocks #40876
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Share Price
$0.0127
Last synced: 2026-08-12
Market Cap
$66.48K
Change (1 day)
-2.31%
Change (1 year)
-67.44%
Country
US
Trade Vincerx Pharma, Inc. (VINC)

Category

Stock split history for Vincerx Pharma, Inc. (VINC)
Vincerx Pharma, Inc. stock (symbol: VINC) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One VINC share bought prior to Aug 13, 2026 would equal to 0 VINC shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE